The study was carried out on 50 thalassemic children and 20 control subjects aged 5-15 years. The cortical thickness in thalassemic children was less than in control subjects. The bone loss was more obvious in girls (P < 0.0005) than in boys (P < 0.05).
The greater bone loss in girls could not be explained by the level of blood hemoglobin because in both sexes the mean value was the same (7.3 f 0.5 g/dl).
Of the 12 thalassemic children observed for 9-24 months, 9 showed no significant bone change, 2 showed an improvement of cortical thickness and only 1 showed bone loss. Of the 11 thalassemic children observed for 25-48 months, 4 showed significant bone loss and 7 no change of the bone density. In both groups the mean value of pretransfusion blood Hb was 7.3 g/dl and the sex distribution was equal. A relationship was found in both control and thalassernic children between bone density and urine phosphorus to urine creatinine ratio.
Speculation
The bone density is less in thalassemic than in control children and this difference is more obvious in girls. An investigation of the hormonal factors which are related to the bone density might give useful information concerning the hormonal status during the prepubertal period in thalassemic girls. This knowledge may help in preventing the severe bone loss in girls. The findings of the investigation may have more practical application in thalassemic girls, who do not need blood transfusions because they have blood hemoglobin values of 7-10 g/dl, but who have the bone lesions of thalassemia. In each individual patient the bone loss requires more than 24 months to become radiologically obvious when the pretransfusion blood hemoglobin is 7-8 g/dl. The bone loss during the course of the disease could be reduced with higher pretransfusion blood hemoglobin values with the complication of iron overload. From a previous study it was shown that thalassemic children have abnormally high phosphaturia. It is therefore likely that phosphorus administration could have beneficial effect on the bone density. Further investigations should be performed to assess the beneficial effect of different pretransfusion blood hemoglobin values and/or the extra oral phosphorus administration on the bone density in thalas'semic children. Apart from the metabolism of phosphorus, that of calcium should also be investigated in thalassemic patients. It will be advisable to measure both ratios (UP:UCr and UCa:UCr) and to relate them to bone density. If a relationship is found then these two ratios can replace the radiologic examination.
The bone density in thalassemic children has been studied very little (13, 15) and in none of the studies have the changes during the course of the disease been investigated. The present work describes 1) a study of the bone density in thalassemic children and the changes of the density during the course of the disease in each thalassemic patient and 2) an attempt to develop a screening test for the condition of bone density in thalassemic patients.
METHODS
In all children duplicate measurements of cortical thickness on x-ray films of the metacarpals of both hands were made (9) . The measurement was made in the thalassemic children every 6 months and in the control subjects once. The Exton-Smith index (6) was used for the estimation of the bone density of each metacarpal because in it the length of metacarpal bone is taken into consideration and the length of the second left metacarpal bone is indirectly related to 1) the weight of the skeleton (bone density) and 2) the height of the body. This is important since thalassemic children are retarded in height in comparison to normal children. The method of Horsman et al. (9) was also used 1) for more accurate results and 2) to follow individual changes of bone density (24) .
Control and thalassemic children did not receive any food for at least 12 hr before the biochemical investigations (overnight). They emptied their bladders in the morning; a collection of urine was made 3 hr later and at the same time a sample of blood was taken. Urine phosphorus (P) to urine creatinine (Cr) concentration ratio (UP:UCr) was measured. Urinary P and urinary Cr were measured as reported in a previous paper (5).
MATERIALS
The group under investigation comprised the following. 1) Fifty children (22 boys and 28 girls) with an equal age distribution (5-15 years) who received regular blood transfusions in the day clinic for thalassemia of the Aghia Sophia Children's Hospital. All had hepatosplenomegaly, anemia, normoblastosis, an abnormal amount of fetal hemoglobin, and typical thalassemic lesions of skull and other bones. In each case both parents were heterozygous for thalassemia as shown by erythrocyte morphology and hemoglobin electrophoresis. Of these patients 12 were observed for 9-24 months and 11 for 2 5 4 8 months. 2) Twenty control subjects (12 boys and 8 girls) aged 5-15 years who were admitted to the hospital for adenoidectomy or tonsillectomy. All control subjects had blood hemoglobin over 11.5 g/dl. Figure 1 shows the mean value and the SD for age and bone density in the thalassemic and control boys. Thalassemic boys had smaller bone density than controls with an equal age distribution (P < 0.05). If we disregard the two thalassemic cases with very low values of bone density, the difference in the bone density had a statistical significance at the level of 10% (0.1 > P > 0.05). Figure 2 shows the mean values and the SD for age and bone density in the thalassemic and control girls. In the thalassemic girls the bone density was markedly less than in the control subjects (P < 0.0005) with an equal age distribution. DOXIADIS ET AL. 
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, x is the bone density in each boy with 95% confidence interval according to the formula x = . ? +-s, as in the chapter on methods. Table 1 shows the mean values and the SD for age, blood Hb, and bone density in all thalassemic children. As it may be seen the bone density was less in the girls than in the boys but the difference was not statistically significant (0.10 > P > 0.05). Figure 3 shows the bone density changes in 12 thalassemic children for a period of observation of 9-24 months. Of the'l2 children, 9 showed no significant change, 2 showed an improvement of cortical thickness, and only 1 showed bone loss. Figure 4 shows the bone density changes in 11 thalassemic children for a period of observation of 25-48 months. Of the 11 children, 4 showed a significant bone loss and 7 showed no change. Figure 5 shows the relation between UP:UCr ratio and bone density in both groups of children. A negative correlation between the two measurements was found (P = 0.05). If we disregard the one thalassemic case with a very low value of bone density and normal UP:UCr ratio (Fig. 5) , the correlation between the two parameters was statistically significant (r -0.5052; P < 0.001). As the UP:UCr ratio increased the bone density decreased. 16, 20) . Although the complicated scanning techniques are considered as more accurate, the morphometric methods d o not fall far behind and there is a close relationship between these two methods (12, 16) . According to Sorenson and Cameron (20) . the presence of fat in the medullary cavity of bone leads to serious error with scanning techniques. Cortical bone is frequently replaced by fat in bone disease. These authors (20) suggest that a reasonably accurate correction for effects of fat in the marrow cavity could be made from radiographs and appropriate correction curves (21) . Thalassemic children have cortical thinning and enlarged marrow cavity with a decrease of erythropoietic tissue in (18) . The less dense bone of thalassemic children can explain the greater tendency of these children to fractures (4, 17) . These would have been more frequent if the thalassemic children had not had a lower level of physical activity. T o increase the bone density one would have to keep hemoglobin values at a higher level (23) with the concomitant advantages, but. also disadvantages and difficulties of such a regime. Another way would be to increase the intake of vitamin D, phosphorus or calcium. Theoretically, the risk of calcification of soft tissues and kidneys by the increased administration of phosphorus and/or calcium and/or vitamin D could not be excluded but this risk is very low, almost nonexistent. Our own experience with phosphorus administration (to be published) shows that this has a beneficial effect on bone density in thalassemic children and none of these patients showed an increase blood calcium and/or urinary calcium to urinary creatinine ratio and/or nephrocalcinosis.
In the thalassemic children, however, the bone density of the girls was less than that of the boys, but the difference had a statistical significance at the level of 10%. The level of blood hemoglobin alone could not explain the sex difference of bone density in thalassemic children. Other factors (hormones, etc.) must be responsible for this. This finding needs further investigation because it may be of importance, especially for the thalassemic females with intermediate type of the disease, who d o not need transfusion, reach adult life, and are therefore more likely to have osteoporosis and to sustain fractures.
The course of bone changes in individual patients has been studied in women with osteoporosis (9. lo), but not in thalassemic children. In normal children an increase of bone density takes observations of the 10 metacarpal bones, twice; f2: mean value of the bone density ( -DL ) in the 10 metacarpal boner trice from the second tilm of the same thalassemic child, 9-24 months aner the first x-ray film, s?: SD of the 20 measuiements of the bone density from the second x-ray film; t expresses the changes of bone density in the same individual with an interval of 9-24 months between the two x-ray films.
DOXIADIS ET AL. place during growth (8) . In thalassemic patients there was either no change or a decrease of bone density. These developments, however, required more than 24 months of radiologic observation, when the pretransfusion blood Hb was 7-8 g/dl.
By using the present technique for estimation of individual changes of bone density in a thalassemic child under a vigorous or low transfusion program we could obtain information concerning the effect of age, of growth spurt, and of puberty on the bone density.
Bone is one of the tissues mainly affected in thalassemic children. A knowledge of the condition of the bones is therefore essential for the assessment of the whole state of health. In order to avoid undue exposure to x-rays we should attempt to find other indirect indications of the condition of bones. Hurwitz et al.
(1 1) found in rachitic rats and Lapatsanis et al. (14) in rachitic children a close inverse relationship between serum phosphorus and rachitic bone lesions but not between serum calcium and the severity of bone lesions. The children in our study did not receive any food for I2 hr and we can assume that the urinary P was coming from the bones (3, 22) . Of the I1 thalassemic children with a UP:UCr ratio less than 0.6 only 3 had abnormally low bone density. In 15 thalassemic children with UP:UCr ratio 0.6 or higher the bone density was at low normal or abnormally low limits. If we disregard the case with very low bone density but with normal UP:UCr ratio, then there was a strong negative correlation between UP:UCr ratio and bone density. If this finding is confirmed by further observations, the measurement of this UP:UCr ratio could reduce the number of radiologic examinations in thalassemic patients.
CONCLUSION
Fifty thalassemic children (22 boys and 28 girls) and 20 control subjects were studied. Twelve of the thalassemic patients were observed for 9-14 months and l l for 2 6 4 8 months. The bone density in thalassemic children was 0.087 f 0.016 in boys and 0.08 1 f 0.009 in girls. The bone density is less in thalassemic than in control children. In thalassemic children the bone density is smaller in girls than in boys. The individual bone loss of thalassemic children in this age group (5-15 years) needs more than 24 months to become radiologically obvious when the pretransfusion blood hemoglobin is 7-8 g/dl. A relationship was found between the ratio of urine phosphorus to urine creatinine concentration and the bone density (P = 0.05).
